Japan Medical Dynamic Marketing, Inc. carries a market capitalization of 23.43B, placing it among publicly traded companies globally. Its enterprise value stands at 19.18B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.43B |
| Enterprise Value | 19.18B |
Japan Medical Dynamic Marketing, Inc. currently has 26.33M shares outstanding.
| Shares Outstanding | 26.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Japan Medical Dynamic Marketing, Inc. trades at a trailing price-to-earnings ratio of 20.76. The price-to-sales ratio is 1.55, and the price-to-book ratio stands at 0.96.
| PE Ratio | 20.76 |
| PS Ratio | 1.55 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Japan Medical Dynamic Marketing, Inc. trades at an EV/EBITDA multiple of 16.99 and an EV/FCF ratio of 1,226.52. The EV/Sales ratio of 1.57 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.99 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.57 |
| EV / EBITDA | 16.99 |
| EV / EBIT | 16.99 |
| EV / FCF | 1,226.52 |
Japan Medical Dynamic Marketing, Inc. maintains a current ratio of 4.82, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.83, indicating elevated leverage, while an interest coverage ratio of 62.49 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.82 |
| Quick Ratio | 0.51 |
| Debt / Equity | 9.83 |
| Debt / EBITDA | 2.17 |
| Interest Coverage | 62.49 |
Japan Medical Dynamic Marketing, Inc. posts a return on equity of 4.75 and a return on invested capital of 3.62.
| Return on Equity (ROE) | 4.75 |
| Return on Assets (ROA) | 2.96 |
| Return on Invested Capital (ROIC) | 3.62 |
| Return on Capital Employed (ROCE) | 4.17 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.34 |
Over the trailing twelve months, Japan Medical Dynamic Marketing, Inc. has paid 147.52M in income taxes, reflecting an effective tax rate of 13.44.
| Income Tax | 147.52M |
| Effective Tax Rate | 13.44 |
Japan Medical Dynamic Marketing, Inc.'s stock has gained approximately 61.93078% over the past 52 weeks. The 50-day moving average sits at 743.26, while the 200-day moving average is 576.69.
| Beta (5Y) | N/A |
| 52-Week Price Change | 61.93078% |
| 50-Day Moving Average | 743.26 |
| 200-Day Moving Average | 576.69 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Japan Medical Dynamic Marketing, Inc. generated 12.23B in revenue and converted that into 911.96M in net income, yielding earnings per share of 36.09. EBITDA reached 1.13B, while operating income came in at 1.13B.
| Revenue | 12.23B |
| Gross Profit | 7.74B |
| Operating Income | 1.13B |
| Pretax Income | 1.10B |
| Net Income | 911.96M |
| EBITDA | 1.13B |
| EBIT | 1.13B |
| Earnings Per Share (EPS) | 36.09 |
Japan Medical Dynamic Marketing, Inc. holds 2.26B in cash and equivalents against 2.45B in total debt, resulting in a net debt position of 135.09M. Total book value stands at 19.71B, with working capital of 17.09B providing operational flexibility.
| Cash & Cash Equivalents | 2.26B |
| Total Debt | 2.45B |
| Net Debt | 135.09M |
| Equity (Book Value) | 19.71B |
| Book Value Per Share | 748.72 |
| Working Capital | 17.09B |
Japan Medical Dynamic Marketing, Inc. operates with a gross margin of 63.30, reflecting its pricing power and cost economics. The operating margin of 9.24 and net profit margin of 7.46 provide insight into operational efficiency.
| Gross Margin | 63.30 |
| Operating Margin | 9.24 |
| Pretax Margin | 8.98 |
| Profit Margin | 7.46 |
| EBITDA Margin | 9.24 |
Japan Medical Dynamic Marketing, Inc.'s most recent stock split took place on May 28, 2002 with a 10:11 split ratio.
| Last Split Date | 5/28/2002 |
| Split Ratio | 10:11 |
Japan Medical Dynamic Marketing, Inc. posts an Altman Z-Score of 3.74, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.74 |